Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Suits allege harm from Pfizer quit-smoking drug
Reuters
Friday, January 15, 2010 - 10:10am
tags:
Pfizer, lawsuits, Chantix
Cell Therapeutics stock sale raises $30M and eyebrows
Fierce Biotech
Friday, January 15, 2010 - 9:57am
tags:
stock offering, Cell Therapeutics
Dems May Seek Billions More From Drug and Device Companies
WSJ Online
Friday, January 15, 2010 - 9:55am
tags:
healthcare reform
J&J recalls several non-prescription drugs
Marketwatch
Friday, January 15, 2010 - 9:53am
tags:
recalls, JNJ
Reality check: Reuters sees Big Pharma growing risk averse
Fierce Biotech
Friday, January 15, 2010 - 9:26am
tags:
Big Pharma, Arena Pharmaceuticals, biotech
Two Biotech Companies that Make 'Green Sense'
Seeking Alpha
Friday, January 15, 2010 - 9:23am
tags:
Gilead Sciences, Genoptix
Biotech Stock Mailbag: Adventrx Pharmaceuticals
TheStreet.com
Friday, January 15, 2010 - 9:21am
tags:
Cord Blood America, Adventrx, Novelos Therapeutics, MannKind, Hemispherx, Cell Therapeutics
A Closer Look at Cubist Pharma
Seeking Alpha
Friday, January 15, 2010 - 9:02am
tags:
Cubist Pharmaceuticals
An 11th-Hour Battle Over Biogenerics In Congress
Pharmalot
Friday, January 15, 2010 - 9:01am
tags:
biogenerics, healthcare reform
Xenoport Says U.S. FDA Won’t Require Advisory Panel
Bloomberg
Friday, January 15, 2010 - 8:54am
tags:
FDA, restless legs syndrome, XenoPort, GSK, Astellas
Pandemic Flu Scare Fades, Vaccine Glut Seen for Glaxo,Baxter
Bloomberg
Friday, January 15, 2010 - 8:51am
tags:
vaccines, GSK, H1N1, Baxter International
Merck: My Favorite Dow 30 Stock
Seeking Alpha
Friday, January 15, 2010 - 8:50am
tags:
Merck
Mass. doctor accused of faking painkiller studies charged with federal health care fraud
Yahoo/AP
Friday, January 15, 2010 - 8:48am
tags:
Massachusetts, health care fraud, Vioxx, Merck, Bextra, Pfizer
Lawsuit Challenges Marketing of Stents
NY Times, NY
Friday, January 15, 2010 - 8:47am
tags:
stents, Boston Scientific, JNJ, lawsuits, Guidant
Pfizer Was Also Questioned in EU On Generic Deals
WSJ Online
Thursday, January 14, 2010 - 4:57pm
tags:
Pfizer, Europe, generics, patents
Hemispherx submits new Ampligen data to FDA
Bizjournals.com
Thursday, January 14, 2010 - 4:16pm
tags:
FDA, Ampligen, Hemispherx
Pfizer's Interest in Enzon May Create Jackpot Payday for CEO Buchalter
BNET Pharma
Thursday, January 14, 2010 - 4:13pm
tags:
Pfizer, Enzon, Jeffrey Buchalter
Moody's raises Teva credit rating
Yahoo/AP
Thursday, January 14, 2010 - 4:12pm
tags:
Teva Pharmaceuticals, credit rating
FDA finds no heart risk with Spiriva inhaler
Yahoo/AP
Thursday, January 14, 2010 - 4:10pm
tags:
Spiriva, FDA, Pfizer, Boehringer Ingelheim
That Novartis-Alcon Deal May Have a Tax Problem
WSJ Online
Thursday, January 14, 2010 - 4:09pm
tags:
M&A, Alcon, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.